E-LIB Suche - Ergebnisse für: Mark Lebwohl

1

Bimekizumab Efficacy through Year 1 in Patients with Modera..:

Han, George ; Gottlieb, Alice ; Armstrong, April...
SKIN The Journal of Cutaneous Medicine. 8 (2024) 2 - p. s369 , 2024

Link: https://doi.org/10.25251..

2

The Burden of Work Productivity and Activity Impairment in ..:

Janak, Jud C. ; Loughlin, Anita M. ; Moore, Page C....
Digestive Diseases and Sciences. , 2024

Link: https://doi.org/10.1007/..

3

Deucravacitinib, a selective, allosteric tyrosine kinase 2 ..:

Blauvelt, Andrew ; Rich, Phoebe ; Sofen, Howard...
Journal of the American Academy of Dermatology. 90 (2024) 4 - p. 775-782 , 2024

Link: https://doi.org/10.1016/..

4

Patients with Psoriatic Arthritis at Biologic Therapy Switc..:

Mease, Philip ; Jones, Eric ; Sima, Adam...
SKIN The Journal of Cutaneous Medicine. 8 (2024) 1 - p. s311 , 2024

Link: https://doi.org/10.25251..

5

Efficacy of Remibrutinib in Patients With Chronic Spontaneo..:

Mosnaim, Giselle ; Gimenez-Arnau, Ana ; Hide, Michihiro...
Journal of Allergy and Clinical Immunology. 153 (2024) 2 - p. AB369 , 2024

Link: https://doi.org/10.1016/..

6

Expected Spesolimab Plasma Exposure following Intravenous a..:

Hawkes, Jason ; Guercio, Jason ; Kurup, Sree..
SKIN The Journal of Cutaneous Medicine. 8 (2024) 2 - p. s359 , 2024

Link: https://doi.org/10.25251..

7

Development of the Generalized Pustular Psoriasis Clinical ..:

Garg, Amit ; Noe, Megan H. ; Anadkat, Milan J....
Journal of the American Academy of Dermatology. 90 (2024) 1 - p. 192-195 , 2024

Link: https://doi.org/10.1016/..

8

Spesolimab Use for Generalized Pustular Psoriasis Flare Pre..:

Merola, Joseph ; Anadkat, Milan ; Bhatia, Neal...
SKIN The Journal of Cutaneous Medicine. 8 (2024) 2 - p. s360 , 2024

Link: https://doi.org/10.25251..

9

Executive Summary: From the Medical Board of the National P..:

James, Warren A. ; Rosenberg, Angela L. ; Wu, Jashin J....
Journal of the American Academy of Dermatology. , 2024

Link: https://doi.org/10.1016/..

10

The Role of Field Cancerization in Selecting Therapies for ..:

Zakria, Danny ; Shah, Milaan ; Burshtein, Joshua...
SKIN The Journal of Cutaneous Medicine. 8 (2024) 3 - p. 1478-1487 , 2024

Link: https://doi.org/10.25251..

11

Bimekizumab 3-year Safety and Tolerability in Moderate to S..:

Lebwohl, Mark ; Strober, Bruce ; Langley, Richard G....
SKIN The Journal of Cutaneous Medicine. 8 (2024) 1 - p. s305 , 2024

Link: https://doi.org/10.25251..

12

Safety and Efficacy of Combination Therapy of Upadacitinib ..:

Amara, Shivkar ; Patel, Aarav ; Lebwohl, Mark
SKIN The Journal of Cutaneous Medicine. 8 (2024) 3 - p. 1574-1580 , 2024

Link: https://doi.org/10.25251..

13

Rapid Reduction and Free or Almost Free of Itch Response Wi..:

Lebwohl, Mark ; Kim, Brian S. ; Alonso-Llamazares, Javier...
SKIN The Journal of Cutaneous Medicine. 8 (2024) 1 - p. s331 , 2024

Link: https://doi.org/10.25251..

14

Deucravacitinib in plaque psoriasis: 2-year safety and effi..:

Lebwohl, Mark ; Warren, Richard B ; Sofen, Howard...
British Journal of Dermatology. 190 (2024) 5 - p. 668-679 , 2024

Link: https://doi.org/10.1093/..

15

Symptoms of Neuropathic Itch:A Report From the Neuropathic ..:

Kim, Brian S. ; Mohawk, Jennifer A. ; Cirulli, Joshua...
SKIN The Journal of Cutaneous Medicine. 8 (2024) 1 - p. s332 , 2024

Link: https://doi.org/10.25251..